Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 286

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Hyperimmune IV Immunoglobulin Treatment

Hung, Ivan F.N., To, Kelvin K.W., Lee, Cheuk-Kwong, Lee, Kar-Lung, Yan, Wing-Wa, Chan, Kenny, Chan, Wai-Ming, Ngai, Chun-Wai, Law, Kin-Ip, Chow, Fu-Loi, Liu, Raymond, Lai, Kang-Yiu, Lau, Candy C.Y., Liu, Shao-Haei, Chan, Kwok-Hung, Lin, Che-Kit, Yuen, Kwok-Yung·2013·Chest

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1378/chest.12-2907

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 29

  1. Cheng, 2012, Two years after pandemic influenza A/2009/H1N1: what have we learned?, Clin Microbiol Rev, 25, 223, 10.1128/CMR.05012-11 · DOI · Paper page
  2. To, 2010, Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection, Postgrad Med J, 86, 515, 10.1136/pgmj.2009.096206 · DOI
  3. Hancock, 2009, Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus, N Engl J Med, 361, 1945, 10.1056/NEJMoa0906453 · DOI · Paper page
  4. Louie, 2009, Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California, JAMA, 302, 1896, 10.1001/jama.2009.1583 · DOI · Paper page
  5. Chan, 2011, The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation, Clin Vaccine Immunol, 18, 305, 10.1128/CVI.00363-10 · doi:10.1128/cvi.00363-10
  6. Gordon, 2010, Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency, Clin Infect Dis, 50, 672, 10.1086/650462 · DOI
  7. Zhou, 2012, A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection, J Infect Dis, 206, 495, 10.1093/infdis/jis378 · doi:10.1093/infdis/jis378
  8. Li, 2010, The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment, Chest, 137, 759, 10.1378/chest.09-3072 · DOI
  9. Davies, 2009, Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome, JAMA, 302, 1888, 10.1001/jama.2009.1535 · DOI · Paper page
  10. Chan, 2010, Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1), Hong Kong Med J, 16, 447
  11. Luke, 2006, Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?, Ann Intern Med, 145, 599, 10.7326/0003-4819-145-8-200610170-00139 · DOI · Paper page
  12. Zhou, 2007, Treatment with convalescent plasma for influenza A (H5N1) infection, N Engl J Med, 357, 1450, 10.1056/NEJMc070359 · DOI · Paper page
  13. Hung, 2011, Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection, Clin Infect Dis, 52, 447, 10.1093/cid/ciq106 · DOI · Paper page
  14. Wong, 2010, Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection, Transfusion, 50, 1967, 10.1111/j.1537-2995.2010.02651.x · doi:10.1111/j.1537-2995.2010.02651.x
  15. Hung, 2010, Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009, Clin Infect Dis, 51, 274, 10.1086/653940 · doi:10.1086/653940
  16. To, 2010, Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection, Clin Infect Dis, 50, 850, 10.1086/650581 · DOI · Paper page
  17. Arankalle, 2010, Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients, PLoS One, 5, 10.1371/journal.pone.0013099 · DOI
  18. Steensberg, 2003, IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans, Am J Physiol Endocrinol Metab, 285, E433, 10.1152/ajpendo.00074.2003 · DOI · Paper page
  19. Monsalvo, 2011, Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes, Nat Med, 17, 195, 10.1038/nm.2262 · DOI · Paper page
  20. To, 2012, High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza, Clin Vaccine Immunol, 19, 1012, 10.1128/CVI.00081-12 · DOI
  21. Jefferson, 2000, Neuraminidase inhibitors for preventing and treating influenza in healthy adults, Cochrane Database Syst Rev
  22. Inoue, 2010, Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours, Emerg Infect Dis, 16, 1633, 10.3201/eid1610.100688 · DOI
  23. Macmillan, 2010, Intravenous immunoglobulin G selectively inhibits IL-1α-induced neutrophil-endothelial cell adhesion, Autoimmunity, 43, 619, 10.3109/08916931003599062 · DOI
  24. Tse, 2011, Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection, PLoS ONE, 6, e22534, 10.1371/journal.pone.0022534 · DOI
  25. Chan, 2010, Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice, PLoS ONE, 5, e13757, 10.1371/journal.pone.0013757 · DOI
  26. Nave, 2011, Obesity-related immunodeficiency in patients with pandemic influenza H1N1, Lancet Infect Dis, 11, 14, 10.1016/S1473-3099(10)70304-2 · DOI
  27. Fowlkes, 2011, Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009, Clin Infect Dis, 52, S60, 10.1093/cid/ciq022 · DOI
  28. Shoemaker, 2012, Integrated network analysis reveals a novel role for the cell cycle in 2009 pandemic influenza virus-induced inflammation in macaque lungs, BMC Syst Biol, 6, 117, 10.1186/1752-0509-6-117 · DOI
  29. Wu, 2010, Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic, Proc Natl Acad Sci U S A, 107, 3269, 10.1073/pnas.0911596107 · DOI

Cited by

See all 286

Metadata

Authors
Hung, I. F. N., To, K. K. W., Lee, C.-K., Lee, K.-L., Yan, W.-W., Chan, K., Chan, W.-M., Ngai, C.-W., Law, K.-I., Chow, F.-L., Liu, R., Lai, K.-Y., Lau, C. C. Y., Liu, S.-H., Chan, K.-H., Lin, C.-K., & Yuen, K.-Y.
Venue
Chest
Publisher
Elsevier BV
Published
2013-08
Volume
144
Issue
2
Pages
464-473
ISSN
0012-3692 (ISSN-L)
OpenAlex
W1964402677
Cited by
286
References
1
FWCI
14.05
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hyperimmune IV Immunoglobulin Treatment. https://app.cochat.ai/papers/10.1378/chest.12-2907
The paper
Hung, I. F. N., To, K. K. W., Lee, C.-K., Lee, K.-L., Yan, W.-W., Chan, K., Chan, W.-M., Ngai, C.-W., Law, K.-I., Chow, F.-L., Liu, R., Lai, K.-Y., Lau, C. C. Y., Liu, S.-H., Chan, K.-H., Lin, C.-K., & Yuen, K.-Y. (2013). Hyperimmune IV Immunoglobulin Treatment. Chest. https://doi.org/10.1378/chest.12-2907

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.